Endogenous cost-effectiveness analysis in health care technology adoption
Read Online
Share

Endogenous cost-effectiveness analysis in health care technology adoption

  • 900 Want to read
  • ·
  • 7 Currently reading

Published by National Bureau of Economic Research in Cambridge, MA .
Written in English


Book details:

Edition Notes

StatementAnupam Jena, Tomas Philipson.
SeriesNBER working paper series -- working paper 15032, Working paper series (National Bureau of Economic Research : Online) -- working paper no. 15032.
ContributionsPhilipson, Tomas J., National Bureau of Economic Research.
Classifications
LC ClassificationsHB1
The Physical Object
FormatElectronic resource
ID Numbers
Open LibraryOL23683713M
LC Control Number2009655983

Download Endogenous cost-effectiveness analysis in health care technology adoption

PDF EPUB FB2 MOBI RTF

1. J Health Econ. Jan;32(1) doi: /co Epub Oct Endogenous cost-effectiveness analysis and health care technology adoption. Jena AB(1), Philipson TJ. Author information: (1)Harvard University, USA. Increased health care spending has placed pressure on public and private payers to prioritize :// Endogenous cost-effectiveness analysis and health care technology adoption Cost-effectiveness (CE) analysis is the main tool used by payers to prioritize coverage of new therapies. We argue that reimbursement based on CE is subject to a form of the “Lucas critique”; the goals of CE policies may not materialize when firms affected by the Abstract. Increased health care spending has been argued to be largely due to technological change. Cost-effectiveness analysis is the main tool used by private and public third-party payers to prioritize adoption of the new technologies responsible for this :// BibTeX @MISC{Jena09isgiven, author = {Anupam Jena and Tomas Philipson and Anupam Jena and Tomas Philipson}, title = {is given to the source. Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption}, year = {}}?doi=

Downloadable (with restrictions)! Increased health care spending has placed pressure on public and private payers to prioritize spending. Cost-effectiveness (CE) analysis is the main tool used by payers to prioritize coverage of new therapies. We argue that reimbursement based on CE is subject to a form of the “Lucas critique”; the goals of CE policies may not materialize when firms Endogenous cost-effectiveness analysis and health care technology adoption Article in Journal of Health Economics 32(1) October with 24 Reads How we measure 'reads' 3. Implications of endogenous cost-effectiveness adoption. In this section we consider the implications for spending and health outcomes of using endogenous CE analysis for technology adoption. Endogenous CE policies and health care spending. The most common rationale for stricter CE policies is to reduce health care ://   Endogenous cost-effectiveness analysis and health care technology adoption Journal of Health Economics, Vol. 32, No. 1 Antihypertensive Drugs: A Perspective on Pharmaceutical Price Erosion and Its